Franklin Genomic Advancements ETF (HELX)

$31.4152

-0.89 (-2.76%)
Rating:
Recommendation:
-
Symbol HELX
Price $31.4152
Beta 0.000
Volume Avg. 0.00M
Market Cap -
Shares () -
52 Week Range 28.623-49.0
1y Target Est -
DCF Unlevered HELX DCF ->
DCF Levered HELX LDCF ->
ROE -
ROA -
Operating Margin -
Debt / Equity -
P/E -
P/B -
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades


None
BATS

Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.